详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Letter 2 regarding "Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma"

0| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Endocrinology and Metabolic Hepatology, The Affiliated Hospital of Qingdao University, Qingdao, China. [2]Department of Gastroenterology and Hepatology, Shanghai East Hospital, Tongji University, Shanghai, China. [3]Department of Gastroenterology and Hepatology, The Affiliated Hospital of Qingdao University, Qingdao, China. [4]Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, the Affiliated Hospital of Qingdao University, Qingdao, China. [5]Department of Infectious Disease and Hepatology, The Affiliated Hospital of Qingdao University, Qingdao, China. [6]Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Eye Center, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China. [7]Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. [8]Yong Loo Lin School of Medicine, National University of Singapore, Singapore. [9]Singapore Eye Research Institute, Singapore National Eye Center, Singapore. [10]Department of Computer Science and Engineering, Shanghai JiaoTong University, Shanghai, China. [11]Tsinghua Medicine, Tsinghua University, Beijing, China. [12]Department of Internal Medicine, Beijing Tsinghua Changgung Hospital, Beijing, China.

出处：

DOI：

ISSN：

关键词： Natural language processing Artificial intelligence Non-alcoholic fatty liver disease Patient education as topic

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 1 区医学

小类 | 2 区胃肠肝病学

最新[2023]版：

大类 | 1 区医学

小类 | 2 区胃肠肝病学

JCR分区：

出版当年[2022]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY

最新[2023]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY

影响因子： 14 最新[2023版] 9.6 最新五年平均 8.9 出版当年[2022版] 6.9 出版当年五年平均 8.337 出版前一年[2021版] 14 出版后一年[2023版]

第一作者：

第一作者机构： [1]Department of Endocrinology and Metabolic Hepatology, The Affiliated Hospital of Qingdao University, Qingdao, China.

共同第一作者：

通讯作者：

通讯机构： [9]Singapore Eye Research Institute, Singapore National Eye Center, Singapore. [11]Tsinghua Medicine, Tsinghua University, Beijing, China. [12]Department of Internal Medicine, Beijing Tsinghua Changgung Hospital, Beijing, China. [*1]Tsinghua Medicine, Tsinghua University, Haidian District, Beijing, 100084, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Glycosyltransferases and non-alcoholic fatty liver disease [2]Glycosyltransferases and non-alcoholic fatty liver disease [3]非酒精性脂肪性肝病的治疗研究 [4]Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease [5]Corilagin prevents non-alcoholic fatty liver disease via improving lipid metabolism and glucose homeostasis in high fat diet-fed mice [6]Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism [7]Non-Alcoholic Fatty Liver Disease Is not Related to the Incidence of Diabetic Nephropathy in Type 2 Diabetes [8]The policies on the use of large language models in radiological journals are lacking: a meta-research study [9]非酒精性脂肪性肝病的流行病学与自然史 [10]The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial